EBIT: Income before interest and taxes.
Evoke Pharma, Inc. (EVOK) had EBIT of $-1.30M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$3.08M |
|
$-1.31M |
|
$0.04M |
|
$3.04M |
|
$4.38M |
|
$-1.30M |
|
$-0.00M |
|
$-1.31M |
|
$-1.31M |
|
$-1.31M |
|
$-1.31M |
|
$-1.31M |
|
$-1.31M |
|
|
EBIT |
$-1.30M |
$-1.30M |
|
2.55M |
|
2.55M |
|
$-0.51 |
|
$-0.51 |
|
| Balance Sheet Financials | |
$16.23M |
|
-- |
|
$0.15M |
|
$16.38M |
|
$10.45M |
|
-- |
|
$0.08M |
|
$10.53M |
|
$5.84M |
|
$5.84M |
|
$5.84M |
|
1.49M |
|
| Cash Flow Statement Financials | |
$-1.00M |
|
-- |
|
$0.03M |
|
$13.60M |
|
$12.62M |
|
$-0.97M |
|
$0.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.55 |
|
-- |
|
-- |
|
-- |
|
0.86 |
|
98.65% |
|
-42.26% |
|
-42.26% |
|
-- |
|
-42.41% |
|
-42.41% |
|
$-1.00M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
0.08 |
|
1.23 |
|
73.38 |
|
-22.36% |
|
-22.36% |
|
-7.98% |
|
-22.36% |
|
$3.91 |
|
$-0.39 |
|
$-0.39 |
|